JOANNE ECENRODE: Open Payments
NPI 1386228351 · LITITZ, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $75 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 2 | $19 |
Products named: TARPEYO, LOKELMA, Fabhalta, ULTOMIRIS, Vanrafia, Kerendia, Veltassa.
Industry payments across PA — which companies pay providers there.
